Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates

17 May 2024

Abstract excerpt

Therapeutic approaches targeting proteins on the surface of cancer cells have emerged as an important strategy for precision oncology. To capitalize on the potential impact of drugs targeting surface proteins, detailed knowledge about the expression patterns of the target proteins in tumor tissues is required. In castration-resistant prostate cancer (CRPC), agents targeting prostate-specific membrane antigen...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Peptidase Inhibition and Analysis
Share to Prostate Cancer Treatment and Research
Share to Radiopharmaceutical Chemistry and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38760413
DOI: 10.1038/s41698-024-00599-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlatesPMID 38760413Read ↗

Assessment of Cell Surface Targets in Metastatic Prostate Cancer: Expression Landscape and Molecular CorrelatesSemantic proximity Read ↗

Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.Semantic proximity Read ↗

Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling.Semantic proximity Read ↗

Trop-2 plasticity is controlled by epithelial-to-mesenchymal transitionSemantic proximity Read ↗

Treatment-related Neuroendocrine Prostate Carcinoma—Diagnostic and Molecular CorrelatesSemantic proximity Read ↗

L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells.Semantic proximity Read ↗

Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors.Semantic proximity Read ↗

Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancerSemantic proximity Read ↗

TROP2 expression is associated with early stage and favorable prognosis in Upper tract urothelial carcinomaSemantic proximity Read ↗

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer PatientsSemantic proximity Read ↗

Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancerSemantic proximity Read ↗

TBX2 Drives Neuroendocrine Prostate Cancer through Exosome-Mediated Repression of miR-200c-3pSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.